Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by stockmonster6on Jun 23, 2021 7:58pm
284 Views
Post# 33439097

THRM CEO Interview

THRM CEO InterviewTaking some time to listen to Mr Fia's interview.  Very interesting.

HC study is taking place in Brampton, been lots of back and forth with HC on this - more to follow essentially.  So that is in progress - end time would be unknown then so they are focusing on the FDA approval.  Once all the results are in, the other needed studies have been done and as I suspected, the documents etc... are ready to go.  
I am not sure what the timeline is for FDA authorization under the Emergency conditions.  Hopefully rather quickly.  

Do watch the interview.  I'm interested in that Benepod - 
I think they have some very other interesting tech, which may not be as glamourous as the AcuVid in our context right now, but still valuable products.
<< Previous
Bullboard Posts
Next >>